Abstract
Treatment of anemia and bleeding in Jehovah’s Witness patients represents a major challenge to medical, anesthetic, and surgical teams. Their beliefs regarding blood transfusion elicit major ethical and legal issues that are often not easy to resolve. A holistic approach, focusing on preoperative optimization, blood loss minimization, and anemia tolerance optimization is key in the successful management of these patients. This is best achieved in centers having the appropriate facilities for surgery and perioperative blood conservation techniques. Counseling patients about the different options they will accept or refuse is also of major importance when developing the individual patient blood management program. While treatment of Jehovah’s Witness patients along the years has led to major advance in bloodless surgery, the principles of patient blood management are universal and should be applied to all patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
West JM. Ethical issues in the care of Jehovah’s Witnesses. Curr Opin Anaesthesiol. 2014;27:170–6.
Hoekema AA, editor. The four major cults. Grand Rapids: William B. Eerdmans; 1963. p. 291.
Petrini C. Ethical and legal aspects of refusal of blood transfusions by Jehovah’s Witnesses, with particular reference to Italy. Blood Transfus. 2014;12(Suppl 1):s395–401.
Beauchamp TL, Childress JF. Principles of biomedical ethics. Oxford: Oxford University Press; 2012.
Vincent JL. Transfusion in the exsanguinating Jehovah’s witness patient—the attitude of intensive-care doctors. Eur J Anaesthesiol. 1991;8:297–300.
Demarco JP. Principlism and moral dilemmas: a new principle. J Med Ethics. 2005;31:101–5.
Hivey S, Pace N, Garside JP, Wolf AR. Religious practice, blood transfusion, and major medical procedures. Paediatr Anaesth. 2009;19:934–46.
Lawson T, Ralph C. Perioperative Jehovah’s Witnesses: a review. Br J Anaesth. 2015;115:676–87.
Gillick v West Norfolk and Wisbech Area Health Authority. UKHL 7. 1985.
Woolley S. Children of Jehovah’s Witnesses and adolescent Jehovah’s Witnesses: what are their rights? Arch Dis Child. 2005;90:715–9.
Woolley S. Jehovah’s Witnesses in the emergency department: what are their rights? Emerg Med J. 2005;22:869–71.
American Society of Anesthesiologists. Ethical guidelines for the anesthesia care of patients with do not resuscitate orders or other directives that limit treatment. Park Ridge; 2009 (updated 2013). https://www.asahq.org.
Vamvakas EC. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice. Transfusion. 2013;53:888–901.
Goodnough LT, Shander A, Spivak JL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg. 2005;101:1858–61.
Goodnough LT, Shander A. Patient blood management. Anesthesiology. 2012;116:1367–76.
Berend K, Levi M. Management of adult Jehovah’s witness patients with acute bleeding. Am J Med. 2009;122:1071–6.
Spence RK, Carson JA, Poses R, et al. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg. 1990;159:320–4.
Smoller BR, Kruskall MS. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med. 1986;314:1233–5.
Chand NK, Subramanya HB, Rao GV. Management of patients who refuse blood transfusion. Indian J Anaesth. 2014;58:658–64.
Richman JM, Rowlingson AJ, Maine DN, Courpas GE, Weller JF, Wu CL. Does neuraxial anesthesia reduce intraoperative blood loss? A meta-analysis. J Clin Anesth. 2006;18:427–35.
Zorrilla-Vaca A, Healy RJ, Mirski MA. A comparison of regional versus general anesthesia for lumbar spine surgery: a meta-analysis of randomized studies. J Neurosurg Anesthesiol. 2016.
Opperer M, Danninger T, Stundner O, Memtsoudis SG. Perioperative outcomes and type of anesthesia in hip surgical patients: an evidence based review. World J Orthop. 2014;5:336–43.
Zhu M, Chen JY, Tan YR, et al. Effects of anesthetic technique on blood loss and complications after simultaneous bilateral total knee arthroplasty. Arch Orthop Trauma Surg. 2015;135:565–71.
Degoute CS. Controlled hypotension: a guide to drug choice. Drugs. 2007;67:1053–76.
Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion. 2004;44:632–44.
Barile L, Fominskiy E, Di Tomasso N, et al. Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis of randomized trials. Anesth Analg. 2017;124(3):743–52.
Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth. 2010;105:401–16.
Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR. How to approach major surgery where patients refuse blood transfusion (including Jehovah’s Witnesses). Ann R Coll Surg Engl. 2005;87:3–14.
Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011:CD001886.
Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg. 2013;100:1271–9.
Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376(2):136–48.
Desborough MJ, Oakland KA, Landoni G, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2017;15(2):263–72.
Code of practice for the surgical management of Jehovah’s Witnesses. London: Royal College of Surgeons; 2002.
Van der Linden P. The physiology of acute isovolaemic anaemia. Acta Anaesthesiol Belg. 2002;53:97–103.
Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299:2304–12.
Mackenzie CF, Moon-Massat PF, Shander A, Javidroozi M, Greenburg AG. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia. Anesth Analg. 2010;110:685–93.
Maevsky E, Ivanitsky G, Bogdanova L, et al. Clinical results of Perftoran application: present and future. Artif Cells Blood Substit Immobil Biotechnol. 2005;33:37–46.
Verdin-Vasquez RC, Zepeda-Perez C, Ferra-Ferrer R, Chavez-Negrete A, Contreras F, Barroso-Aranda J. Use of perftoran emulsion to decrease allogeneic blood transfusion in cardiac surgery: clinical trial. Artif Cells Blood Substit Immobil Biotechnol. 2006;34:433–54.
Shander A, Javidroozi M, Naqvi S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion. Transfusion. 2014;54:2688–95.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Lerminiaux, C., Van der Linden, P. (2018). The Jehovah’s Witness Patient. In: Fellahi, JL., Leone, M. (eds) Anesthesia in High-Risk Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-60804-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-60804-4_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60803-7
Online ISBN: 978-3-319-60804-4
eBook Packages: MedicineMedicine (R0)